484 related articles for article (PubMed ID: 25277682)
41. New Insights into the Role of Oxidative Stress Mechanisms in the Pathophysiology and Treatment of Multiple Sclerosis.
Adamczyk B; Adamczyk-Sowa M
Oxid Med Cell Longev; 2016; 2016():1973834. PubMed ID: 27829982
[TBL] [Abstract][Full Text] [Related]
42. Lipid peroxidation: a possible role in the induction and progression of chronic periodontitis.
Tsai CC; Chen HS; Chen SL; Ho YP; Ho KY; Wu YM; Hung CC
J Periodontal Res; 2005 Oct; 40(5):378-84. PubMed ID: 16105090
[TBL] [Abstract][Full Text] [Related]
43. Differences in blood and semen oxidative status in fertile and infertile men, and their relationship with sperm quality.
Benedetti S; Tagliamonte MC; Catalani S; Primiterra M; Canestrari F; De Stefani S; Palini S; Bulletti C
Reprod Biomed Online; 2012 Sep; 25(3):300-6. PubMed ID: 22818093
[TBL] [Abstract][Full Text] [Related]
44. Serum malondialdehyde as a lipid peroxidation marker in multiple sclerosis patients and its relation to disease characteristics.
Ghonimi NAM; Elsharkawi KA; Khyal DSM; Abdelghani AA
Mult Scler Relat Disord; 2021 Jun; 51():102941. PubMed ID: 33895606
[TBL] [Abstract][Full Text] [Related]
45. [Processes of free radical lipid peroxidation with a particular regard to the role of paraoxonase-1 in the pathogenesis of multiple sclerosis].
Berbecki J; Mitosek-Szewczyk K; Kurzepa J; Nastaj M; Łobejko K; Stelmasiak Z
Wiad Lek; 2011; 64(1):31-6. PubMed ID: 21812361
[TBL] [Abstract][Full Text] [Related]
46. [Lipid peroxidation and antioxidant defence enzyme activity in multiple sclerosis].
Pasichna EP; Morozova RP; Donchenko HV; Vinychuk SM; Kopchak OO
Ukr Biokhim Zh (1999); 2007; 79(5):165-74. PubMed ID: 18357791
[TBL] [Abstract][Full Text] [Related]
47. Serum paraoxonase and arylesterase activity and oxidative status in patients with multiple sclerosis.
Kirbas A; Kirbas S; Anlar O; Efe H; Yilmaz A
J Clin Neurosci; 2013 Aug; 20(8):1106-9. PubMed ID: 23669169
[TBL] [Abstract][Full Text] [Related]
48. Transferrin in patients with multiple sclerosis: a comparison among various subgroups of multiple sclerosis patients.
Zeman D; Adam P; Kalistová H; Sobek O; Kelbich P; Andel J; Andel M
Acta Neurol Scand; 2000 Feb; 101(2):89-94. PubMed ID: 10685854
[TBL] [Abstract][Full Text] [Related]
49. Serum antioxidant activities, malondialdehyde and nitric oxide levels in human cutaneous leishmaniasis.
Serarslan G; Yilmaz HR; Söğüt S
Clin Exp Dermatol; 2005 May; 30(3):267-71. PubMed ID: 15807687
[TBL] [Abstract][Full Text] [Related]
50. Protective role of antioxidative food factors in oxidative stress caused by hyperglycemia.
Osawa T; Kato Y
Ann N Y Acad Sci; 2005 Jun; 1043():440-51. PubMed ID: 16037265
[TBL] [Abstract][Full Text] [Related]
51. Influence of therapy on the antioxidant status in patients with melanoma.
Gadjeva V; Dimov A; Georgieva N
J Clin Pharm Ther; 2008 Apr; 33(2):179-85. PubMed ID: 18315784
[TBL] [Abstract][Full Text] [Related]
52. Evaluation of oxidative and nitrosative stress in relapsing remitting multiple sclerosis: effect of corticosteroid therapy.
Seven A; Aslan M; Incir S; Altıntaş A
Folia Neuropathol; 2013; 51(1):58-64. PubMed ID: 23553138
[TBL] [Abstract][Full Text] [Related]
53. Exercise in systemic sclerosis intensifies systemic inflammation and oxidative stress.
Hargardóttir H; van Helvoort HA; Vonk MC; van den Hoogen FH; Dekhuijzen PN; Heijdra YF
Scand J Rheumatol; 2010; 39(1):63-70. PubMed ID: 20132073
[TBL] [Abstract][Full Text] [Related]
54. Evaluation of serum arsenic and its effects on antioxidant alterations in relapsing-remitting multiple sclerosis patients.
Juybari KB; Ebrahimi G; Momeni Moghaddam MA; Asadikaram G; Torkzadeh-Mahani M; Akbari M; Mirzamohammadi S; Karimi A; Nematollahi MH
Mult Scler Relat Disord; 2018 Jan; 19():79-84. PubMed ID: 29156301
[TBL] [Abstract][Full Text] [Related]
55. Disability in patients with multiple sclerosis: influence of insulin resistance, adiposity, and oxidative stress.
Oliveira SR; Simão AN; Kallaur AP; de Almeida ER; Morimoto HK; Lopes J; Dichi I; Kaimen-Maciel DR; Reiche EM
Nutrition; 2014 Mar; 30(3):268-73. PubMed ID: 24484677
[TBL] [Abstract][Full Text] [Related]
56. Glyoxalase I A111E, paraoxonase 1 Q192R and L55M polymorphisms: susceptibility factors of multiple sclerosis?
Sidoti A; Antognelli C; Rinaldi C; D'Angelo R; Dattola V; Girlanda P; Talesa V; Amato A
Mult Scler; 2007 May; 13(4):446-53. PubMed ID: 17463067
[TBL] [Abstract][Full Text] [Related]
57. Oxidative stress in patients with newly diagnosed multiple sclerosis: any association with subclinical atherosclerosis?
Sivakova M; Siarnik P; Filippi P; Vlcek M; Imrich R; Turcani P; Zitnanova I; Penesova A; Radikova Z; Kollar B
Neuro Endocrinol Lett; 2019 Nov; 40(3):135-140. PubMed ID: 31816220
[TBL] [Abstract][Full Text] [Related]
58. The role of oxidative stress and haematological parameters in relapsing-remitting multiple sclerosis in Kurdish population.
Rasoul AA; Khudhur ZO; Hamad MS; Ismaeal YS; Smail SW; Rasul MF; Mohammad KA; Bapir AA; Omar SA; Qadir MK; Rajab MF; Salihi A; Kaleem M; Rizwan MA; Qureshi AS; Iqbal ZM; Qudratullah
Mult Scler Relat Disord; 2021 Nov; 56():103228. PubMed ID: 34492630
[TBL] [Abstract][Full Text] [Related]
59. Decreased Cerebrospinal Fluid Antioxidative Capacity Is Related to Disease Severity and Progression in Early Multiple Sclerosis.
Voortman MM; Damulina A; Pirpamer L; Pinter D; Pichler A; Enzinger C; Ropele S; Bachmaier G; Archelos JJ; Marsche G; Khalil M
Biomolecules; 2021 Aug; 11(9):. PubMed ID: 34572477
[No Abstract] [Full Text] [Related]
60. Cerebrospinal fluid levels of L-glutamate signal central inflammatory neurodegeneration in multiple sclerosis.
Stampanoni Bassi M; Nuzzo T; Gilio L; Miroballo M; Casamassa A; Buttari F; Bellantonio P; Fantozzi R; Galifi G; Furlan R; Finardi A; De Rosa A; Di Maio A; Errico F; Centonze D; Usiello A
J Neurochem; 2021 Dec; 159(5):857-866. PubMed ID: 34547109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
